19 June 2013
Keywords: Forest Labs, Carl Icahn, Proxy fight, Board nominations
Article | 20 June 2012
In a second proxy fight against US drugmaker Forest Laboratories (NYSE: FRX), billionaire investor Carl Icahn has nominated four individuals ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.